Healios KK
OTC:HLOSF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Healios KK
OTC:HLOSF
|
JP |
|
CSL Ltd
ASX:CSL
|
AU |
|
S
|
Swiss Prime Site AG
DUS:SU1N
|
CH |
|
V
|
VF Corp
F:VFP
|
US |
|
Zespol Elektrocieplowni Wroclawskich Kogeneracja SA
F:2ZO
|
PL |
|
AML3D Ltd
F:4YP
|
AU |
|
Ship Healthcare Holdings Inc
F:5EZ
|
JP |
|
P
|
PGT Holdings JSC
VN:PGT
|
VN |
|
Cashbuild Ltd
OTC:CBLDF
|
ZA |
|
A
|
Anam Electronics Co Ltd
KRX:008700
|
KR |
|
C
|
China Energy Engineering Corp Ltd
F:2E5
|
CN |
|
Z
|
Zimmer Biomet Holdings, Inc
F:ZIM
|
US |
|
Amadeus IT Group SA
F:AI3A
|
ES |
|
Y
|
Yum! Brands Inc
XMUN:TGR
|
US |
|
Nel ASA
F:D7G
|
NO |
|
Kyowa Electronic Instruments Co Ltd
TSE:6853
|
JP |
|
Pirelli and C. S.p.a
MIL:PIRC
|
IT |
|
i-mobile Co Ltd
TSE:6535
|
JP |
|
Hannan Metals Ltd
XTSX:HAN
|
CA |
|
M
|
ManpowerGroup Inc
F:MPW
|
US |
|
Science Group PLC
LSE:SAG
|
UK |
|
A
|
Avaland Bhd
KLSE:AVALAND
|
MY |
|
Skane mollan AB
STO:SKMO
|
SE |
|
Adveritas Ltd
F:4TM
|
AU |
Intrinsic Value
Is HLOSF undervalued or overvalued?
See the intrinsic value estimate for 
Healios KK and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Healios KK Does
Healios KK is a Japanese biotechnology company that develops regenerative medicine and cell therapy products. Its core work is to turn living cells into treatments for serious conditions such as stroke and acute respiratory failure, then move those therapies through testing, approval work, and partnering. It is not a traditional drugmaker with a wide catalog of medicines; it is closer to a specialist developer of advanced therapies.
- Headquarters
- Japan JP
- Employees
- 75
- IPO date
- Jun 16, 2015
Revenue & Expenses Breakdown
Healios KK
Earnings Waterfall
Healios KK
The intrinsic value for Healios KK (HLOSF) under the Base Case is hidden USD.
Compared with the current market price of 1.8 USD, the stock appears hidden.